专利检索 ap:("Bayer Pharmaceuticals Corporation") AND inv:"SAMUELS, Isa" 第 1 页

1.

发明公开
USE OF PARAPOX B2L PROTEIN TO TREAT CANCER AND MODIFY IMMUNE RESPONSES 审中-公开
标题翻译：使用本Parapox B2L蛋白用于产生免疫应答的抗原内源增强药物。

公开(公告)号：EP1499355A2

公开(公告)日：2005-01-26

申请号：EP02789997.0

申请日：2002-12-06

申请人： Bayer Pharmaceuticals Corporation

发明人： CASSELL, Delanie , TEPPER, Jeffrey, S. , SAMUELS, Isa , DUBOIS-STRINGFELLOW, Nathalie

IPC分类号： A61K45/00 , A61K39/275 , A61K48/00 , C12Q1/02 , G01N33/53 , G01N33/566

CPC分类号： C07K14/005 , A61K39/39 , A61K2039/53 , A61K2039/54 , A61K2039/55516 , C07K2319/21 , C07K2319/40 , C12N2710/24222 , C12N2710/24233

摘要： A purified Parapoxvirus ovis envelope protein termed 'B2L' can be used as a monotherapeutic agent. B2L protein also can be used in screening methods to identify potential therapeutic agents for modulating a subject's immune response to the B2L protein.